Hurry Up And Wait To Sell: DB Pharm Korea Signs Caldolor Licensing Deal
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Although DB Pharm Korea signed a licensing deal to sell Cumberland Pharmaceuticals' injectable ibuprofen Caldolor, the Korean firm does not think it will be able to sell the product in Korean hospitals anytime soon